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Background
The cyclic nucleotide monophosphates cGMP and cAMP
play an essential role in many signaling pathways. The
identification and profiling of cGMP- and cAMP-binding
proteins is an important step in order to elucidate the
molecular basis of these pathways. In order to develop a
tool to specifically target cGMP- and cAMP-binding pro-
teins, we synthesized cGMP- and cAMP Capture Com-
pounds™ (CCs). CCs are trifunctional small molecule
probes that carry a small molecule as the selectivity func-
tion attached to a scaffold that in addition contains a
photo-activatable reactivity function and biotin as a sort-
ing function. We here explored the capability of the
cAMP- and cGMP Capture Compound Mass Spectrometry
(CCMS) approach to display the proteome subset of
cGMP-and cAMP-binding proteins.
Methods
In the CCMS workflow, the selectivity group (in this case,
derivatives of cGMP or cAMP) first provides equilibrium
binding of the CC to the target proteins. Second, upon
irradiation, the reactivity function freezes this interaction
through covalent cross-link to the target proteins. Third,
using streptavidin magnetic beads, the CC-protein conju-
gates can be easily isolated from the complex protein mix-
ture via the sorting function of the CC. The captured
proteins are then directly subjected to proteolytic on-bead
cleavage and automated LC-MS/MS based protein identi-
fication. We applied this workflow to protein mixtures
from human derived HepG2 cells, and solubilized pro-
teins from rat synaptosomes.
Results
From HepG2 cell lysate (500 μg protein input), regulatory
subunits of PKA as well as cGMP-dependent protein
kinases were captured and identified. From solubilized rat
synaptosomes (60–80 μg protein input), in addition to
the kinase subunits, several phosphodiesterases, Rap gua-
nine nucleotide exchange factors, as well as HCN ion
channels were captured and identified, with partially
overlapping, but also partially distinct selectivity profiles
observed with different CCs. In addition, several potential
and  bona fide interaction partners of cyclic nucleotide-
binding proteins, such as IP3-receptors and A-kinase
anchoring proteins were identified as well.
Conclusion
We here demonstrate that CCs with derivatives of cGMP
or cAMP as selectivity group are unique tools to specifi-
cally target proteins in the cGMP/cAMP-dependent signal-
ing pathways. Notably, cGMP-/cAMP-CCMS can
successfully address even low-abundant transmembrane
ion channels at an unprecedented sensitivity from minute
amounts of complex protein mixtures.
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